TSX:WLLW - Post Discussion
Post by
HGBlog on Dec 16, 2020 9:20am
Willow selects contract manufacturer for CBG production
VANCOUVER, BC, Dec. 16, 2020 /CNW/ – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its commercialization plan by selecting a highly-regarded contract manufacturing organization (“CMO“) to manufacture its first cannabinoid, cannabigerol (“CBG“), with its first commercial scale multi-kilogram run scheduled in Q1 2021...
For full news release:
https://howardgroupinc.com/2020/12/willow-biosciences-advances-its-commercialization-plan-first-commercial-production-expected-in-early-2021/
Be the first to comment on this post